Featured product
Fatty Liver Detox
Grade 1 fatty liver means your ultrasound shows a mild build-up of fat in the liver, the lowest of three grades. It is common, often found by chance, and the best-studied way to reduce it is steady weight loss through diet and exercise, not medicine [3][7].
The grade tells you how much fat the scan can see. It does not tell you whether the liver is scarred, and scarring is what matters most for long-term health [3].
What does grade 1 fatty liver mean on an ultrasound?
Doctors call fat in the liver "steatosis". On ultrasound, a liver with fat looks brighter than normal.
The Indian National Association for the Study of the Liver (INASL) describes grade 1, or mild, fatty liver as "increased echogenicity" (brightness) of the liver compared with the spleen and right kidney [3]. The blood vessels inside the liver are still clearly visible.
Two limits matter. Ultrasound is less accurate when less than about 30% of the liver is fat, and it depends on the person reading the scan [3]. A meta-analysis (a study that pools many studies) of 49 studies found ultrasound picked up moderate to severe fatty liver with 84.8% sensitivity and 93.6% specificity, but the figures were for moderate to severe fat, not mild [5]. So a grade 1 finding sits close to the edge of what ultrasound can detect.
What is the difference between grade 1, grade 2 and grade 3 fatty liver?
| Ultrasound grade | What the radiologist sees |
|---|---|
| Grade 1 (mild) | Liver brighter than the spleen and right kidney; vessels still clear |
| Grade 2 (moderate) | Blurring of the blood vessels inside the liver |
| Grade 3 (severe) | Deep loss of the sound signal; the diaphragm behind the liver is hard to see |
Source: INASL guidance, Table 2 [3]. None of the three grades measures scarring (fibrosis). A person with fatty liver grade 2 may have no scarring, and a person with grade 1 may have some. That is why the blood tests later in this guide matter.
What is MASLD, and why did doctors stop saying NAFLD?
In 2023, liver societies from around the world agreed to rename non-alcoholic fatty liver disease (NAFLD) as metabolic dysfunction-associated steatotic liver disease, or MASLD [1]. Of the 236 panellists from 56 countries, 61% felt the word "non-alcoholic" was stigmatising and 66% felt the same about "fatty" [1]. The new name puts metabolic dysfunction at the centre as the main driver [2].
INASL adopted the new name in 2025 [2]. For Indian adults, MASLD means fat in the liver plus at least one of these: overweight or central obesity (BMI of 23 or more, or a waist above 90 cm in men or 80 cm in women), raised blood sugar or HbA1c of 5.7% or more, blood pressure of 130/85 or more, raised triglycerides, or low HDL cholesterol [2]. Your doctor may now write "MASLD" where an older report said "fatty liver".
How common is fatty liver in India?
Very common. A 2022 meta-analysis led by researchers at AIIMS New Delhi and SGPGI Lucknow pooled 50 studies, including data on 23,581 adults. It estimated that 38.6% of Indian adults have fatty liver [4]. In people at higher risk, such as those with diabetes or obesity, the figure was 52.8% [4].
Being slim does not rule it out: about 17% of Indians with fatty liver have a normal BMI [3].
Is grade 1 fatty liver serious?
Usually not in the short term. INASL notes that scarring progresses slowly in most people, but faster in about 20% to 30% [3]. You cannot tell which group you are in from the ultrasound grade alone.
Read the report as an early signal of metabolic strain, and as the right time to act and to check for scarring.
How to reduce fatty liver: how much weight do you need to lose?
The clearest evidence comes from a 2015 study by Vilar-Gomez and colleagues. They followed 293 adults with biopsy-proven steatohepatitis (fatty liver with inflammation) through a 52-week lifestyle programme, with a liver biopsy at the start and at the end [6].
- Of those who lost 5% or more of their body weight, 58% saw the inflammation clear [6].
- Among those who lost 10% or more, 90% saw it clear and 45% saw scarring improve [6].
- Only 30% of the group managed to lose 5% or more [6].
These patients had more advanced disease than most grade 1 readers. The 2024 European guideline advises a sustained loss of at least 5% to reduce liver fat, 7% to 10% to reduce inflammation, and 10% or more to improve scarring [7]. INASL recommends a 7% to 10% target for Indians who are overweight or obese [3].
For a 75 kg adult, 5% is under 4 kg. That is the first goal.
What is the best fatty liver diet for Indians?
INASL advises that total calories matter more than any named diet. It recommends cutting daily intake by about 30%, or 500 to 1,000 kcal, mainly from carbohydrates and fats in the staple diet [3]. It also advises that a healthy version of your usual local diet is easier to keep up than an imported one such as the Mediterranean diet [3].
In practice, for an Indian kitchen:
- Smaller portions of rice, roti and other refined grains, with more dal, vegetables, salads and sprouts on the plate.
- Protein at each meal: dal, chana, rajma, paneer, curd, eggs, fish or chicken.
- Fruit whole, not as juice.
- Measured cooking oil rather than free pouring.
Which foods to avoid with fatty liver?
INASL sets clear limits [3]:
- Added and free sugars: below 10% of daily calories. Sweetened chai and coffee, mithai, packaged juices, colas and sweetened lassi add up fast.
- Fructose and sweetened drinks: "curtailed", in INASL's words [3].
- Saturated fat: below 10% of calories. Ghee, butter and cream count.
- Trans fats: below 1% of calories. Vanaspati, and snacks fried in oil reused many times, are the common sources.
- Total fat: below 30% of calories.
On coffee, INASL notes some evidence for more than two cups a day, but warns that the Indian habit of adding sugar and milk or cream may cancel it out [3].
How much exercise helps fatty liver?
INASL recommends moderate aerobic or resistance exercise for 30 to 45 minutes a day, at least 5 days a week, adding up to at least 200 minutes a week, whatever your body weight [3]. Brisk walking, cycling and swimming all count, and strength training can add to them [3].
The European guideline prefers more than 150 minutes of moderate activity, or 75 minutes of vigorous activity, a week [7].
Is any alcohol safe with fatty liver?
INASL defines significant drinking in Indians as more than 20 g of alcohol a day, for both men and women [3]. The European guideline advises that people with fat in the liver should be discouraged from drinking, and that anyone with advanced scarring or cirrhosis should stop completely [7].
Under the new naming, a person with MASLD who also drinks 140 to 350 g a week (women) or 210 to 420 g a week (men) is placed in a separate group called MetALD [1].
Which blood tests should you ask your doctor about?
- ALT and AST. These are liver enzymes. Raised levels suggest liver cells are under stress, but normal levels do not rule out disease. INASL says they should not be used to tell simple fat from inflammation [3].
- FIB-4. This is a score your doctor works out from your age, AST, ALT and platelet count [3]. It estimates the chance of significant scarring.
INASL uses these FIB-4 cut-offs [3]:
- Below 1.3: advanced scarring is unlikely. Care can usually stay with your family doctor.
- 1.3 to 2.67: a grey zone. Further testing, such as a FibroScan (a painless scan that measures liver stiffness), is often the next step.
- Above 2.67: advanced scarring is likely. Specialist review is needed.
INASL also advises screening everyone with fatty liver for hepatitis B and C [3].
When should you see a hepatologist?
INASL advises referral to a specialist centre if your FIB-4 falls in the grey zone or above it, or if different tests disagree [3]. See a doctor promptly, without waiting for a routine visit, if you notice yellowing of the eyes or skin, swelling of the belly or legs, confusion, or blood in vomit or stool [17]. These point to more than mild fat and need urgent review. If you have diabetes as well, ask your doctor about a scarring (fibrosis) test. The European guideline singles out this group for that testing [7].
What are milk thistle benefits for the liver, and what about other supplements?
No supplement replaces weight loss, exercise and medical follow-up. INASL's guidance does not recommend any herbal product for fatty liver [3].
Several plant compounds have been studied for liver support. B'spoke's Fatty Liver Detox combines four of them.
Tell your doctor about any supplement you take, and check with them first if you are pregnant, breastfeeding or on medication, especially blood thinners or diabetes medicines.
Related reading on B'spoke:
- How high-carb, low-fibre diets affect metabolic health
- Why hydrogenated oils are harmful
- How compounds like curcumin act on inflammation
Frequently asked questions
Can grade 1 fatty liver go away? Often, yes. Liver fat responds to weight loss; a sustained 5% loss is the level linked with less liver fat [7]. Your doctor can confirm change on a repeat scan.
Can thin people get fatty liver? Yes. About 17% of Indians with fatty liver have a normal BMI [3]. Waist size and blood sugar matter as well as weight.
Do I need a liver biopsy for grade 1 fatty liver? Usually not. Blood scores such as FIB-4, and a FibroScan if needed, are used first [3]. A biopsy is kept for unclear cases.
How long does it take for grade 1 fatty liver to improve? Plan in months, not weeks. In the main weight-loss study, change was measured at 52 weeks [6]. Recheck with your doctor.
Is fatty liver in children a concern in India? Yes. A 2022 Indian meta-analysis estimated 35.4% of children studied had fatty liver, rising to 63.4% in children with obesity [4]. A child with this finding should be seen by a paediatrician.
Written by Dinesh Dagar.
This article is for general information. It is not a diagnosis or a substitute for advice from your doctor. Supplements are not a replacement for medical care.
References
- Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542-1556. doi:10.1016/j.jhep.2023.06.003. PMID: 37364790.
- Duseja A, De A, Singh SP, et al. Adoption of the new nomenclature of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Indian National Association for Study of the Liver (INASL): implications for the INASL guidance paper on NAFLD. J Clin Exp Hepatol. 2025;15:102590. doi:10.1016/j.jceh.2025.102590. PMID: 40535844.
- Duseja A, Singh SP, De A, et al. Indian National Association for Study of the Liver (INASL) guidance paper on nomenclature, diagnosis and treatment of nonalcoholic fatty liver disease (NAFLD). J Clin Exp Hepatol. 2023;13(2):273-302. doi:10.1016/j.jceh.2022.11.014. PMID: 36950481.
- Shalimar, Elhence A, Bansal B, et al. Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis. J Clin Exp Hepatol. 2022;12(3):818-829. doi:10.1016/j.jceh.2021.11.010. PMID: 35677499.
- Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082-1090. doi:10.1002/hep.24452. PMID: 21618575.
- Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367-378.e5. doi:10.1053/j.gastro.2015.04.005. PMID: 25865049.
- European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes Facts. 2024;17(4):374-444. doi:10.1159/000539371. PMID: 38852583.
- Wah Kheong C, Nik Mustapha NR, Mahadeva S. A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2017;15(12):1940-1949.e8. doi:10.1016/j.cgh.2017.04.016. PMID: 28419855.
- Navarro VJ, Belle SH, D'Amato M, et al. Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: a randomized, double-blind, placebo controlled trial. PLoS One. 2019;14(9):e0221683. doi:10.1371/journal.pone.0221683. PMID: 31536511.
- Li S, Duan F, Li S, Lu B. Administration of silymarin in NAFLD/NASH: a systematic review and meta-analysis. Ann Hepatol. 2024;29(2):101174. doi:10.1016/j.aohep.2023.101174. PMID: 38579127.
- Rahmani S, Asgary S, Askari G, et al. Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial. Phytother Res. 2016;30(9):1540-1548. doi:10.1002/ptr.5659. PMID: 27270872.
- Aragón-Vela J, Sánchez-Oliver AJ, Huertas JR, Casuso RA. Does curcumin improve liver enzymes levels in nonalcoholic fatty liver disease? A systematic review, meta-analysis, and meta-regression. Phytother Res. 2024;38(8):4261-4271. doi:10.1002/ptr.8274. PMID: 38965866.
- Pervez MA, Khan DA, Slehria AUR, Ijaz A. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial. Complement Ther Med. 2020;52:102494. doi:10.1016/j.ctim.2020.102494. PMID: 32951743.
- Pervez MA, Khan DA, Mirza SA, et al. Comparison of delta-tocotrienol and alpha-tocopherol effects on hepatic steatosis and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: a randomized double-blind active-controlled trial. Complement Ther Med. 2022;70:102866. doi:10.1016/j.ctim.2022.102866. PMID: 35933083.
- Chin KY, Ekeuku SO, Chew DCH, Trias A. Tocotrienol in the management of nonalcoholic fatty liver disease: a systematic review. Nutrients. 2023;15(4):834. doi:10.3390/nu15040834. PMID: 36839192.
- Fateh HL, Rashid SA, Muhammad SS, et al. Comparing effects of beetroot juice and Mediterranean diet on liver enzymes and sonographic appearance in patients with non-alcoholic fatty liver disease: a randomized control trials. Front Nutr. 2023;10:1181706. doi:10.3389/fnut.2023.1181706. PMID: 37662597.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Symptoms & causes of cirrhosis. Last reviewed June 2023. https://www.niddk.nih.gov/health-information/liver-disease/cirrhosis/symptoms-causes
- Jin Y, Wang X, Chen K, et al. Silymarin decreases liver stiffness associated with gut microbiota in patients with metabolic dysfunction-associated steatotic liver disease: a randomized, double-blind, placebo-controlled trial. Lipids Health Dis. 2024;23:239. doi:10.1186/s12944-024-02220-y. PMID: 39097726.